IGXT - IntelGenx Technologies Corporation

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• IntelGenx GAAP EPS of -$0.02, revenue of $0.14M
• IntelGenx gets amended license to carry out 3rd party testing in Canada
• IntelGenx GAAP EPS of -$0.02, revenue of $0.16M
• IntelGenx reports Q4 results
• IntelGenx migraine therapy accepted for FDA review
• IntelGenx reports Q3 results
• IntelGenx gains as FDA assigns action date for generic pain therapy
• IntelGenx reports Q2 results
• IntelGenx GAAP EPS of $0.02, revenue of $0.24M
• IntelGenx slumps 10% after fourth quarter's results
• IntelGenx reports Q4 results
• IntelGenx resumes dosing in phase 2a Alzheimer’s Disease study of Montelukast VersaFilm
• IntelGenx reports Q3 results
• IntelGenx to resume patient screening in mid-stage Alzheimer’s Disease trial
• IntelGenx slumps 8% amid announcement to up-list to Toronto Stock Exchange
• IntelGenx and Aquestive ink deal to market Tadalafil oral films in the U.S.
• IntelGenx completes initial shipment of CBD Filmstrips under Heritage Cannabis partnership
• IntelGenx reports Q2 results
• IntelGenx reports Q1 results
• IntelGenx expands psychedelics collaboration with ATAI Life Sciences